Cargando…
Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult βENaC-Tg Mice
BACKGROUND: Elevated levels of the cysteine protease cathepsin S (CatS) are associated with chronic mucoobstructive lung diseases such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). We have previously demonstrated that prophylactic treatment with a CatS inhibitor from birt...
Autores principales: | Brown, Ryan, Small, Donna M., Doherty, Declan F., Holsinger, Leslie, Booth, Robert, Williams, Richard, Ingram, Rebecca J., Elborn, J. Stuart, Mall, Marcus A., Taggart, Clifford C., Weldon, Sinéad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004367/ https://www.ncbi.nlm.nih.gov/pubmed/33828414 http://dx.doi.org/10.1155/2021/6682657 |
Ejemplares similares
-
Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S
por: Haerteis, Silke, et al.
Publicado: (2012) -
The N terminus of α-ENaC mediates ENaC cleavage and activation by furin
por: Kota, Pradeep, et al.
Publicado: (2018) -
Cathepsin B increases ENaC activity leading to hypertension early in nephrotic syndrome
por: Larionov, Alexey, et al.
Publicado: (2019) -
ENaC activation by proteases
por: Anand, Deepika, et al.
Publicado: (2022) -
Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease
por: McKelvey, Michael C., et al.
Publicado: (2021)